Lindus Health is a London- and New York-based 'anti-CRO' that runs clinical trials radically faster and more reliably by combining fully integrated CRO services with its own in-house trial-management technology. Its eClinical platform, Citrus, uses AI to optimize study design, automate central monitoring of study data, and enable instant biostatistics, replacing the fragmented stack of vendors typical in legacy contract research. By owning both the operations and the software, Lindus positions itself to leverage big data and AI across the trial lifecycle, from protocol design to data analysis. The company is backed by a strategic advisory board including Moderna founder Robert Langer and former Eli Lilly CMO Tim Garnett. In January 2025 it raised a $55M Series B led by Balderton Capital, with Visionaries Club, Creandum, Firstminute, and Seedcamp.
Lindus Health
ActiveThe anti-CRO running radically faster, AI-enabled clinical trials end to end
Total raised
$55M
1 round
Stage
Series B
Team
201-500
since 2021
Pricing
Freemium
free plan
Founded
2021
London, United Kingdom
Agent-ready
—
Citrus eClinical trial platform
Full-service integrated CRO operations
AI-optimized study design
Automated central data monitoring
Instant biostatistics
Patient recruitment support
End-to-end trial management
Big-data and AI across the trial lifecycle
10/100
Early
MCP server
Public API
Webhooks
OAuth 2.0
SDKs
No public agent surfaces detected yet.
— Series B $55M incl. Balderton Capital +4
Capital network
$78M raised ·5 backers·10 network links
- Backers5
- Shared portfoliocompanies these backers also fund
- Extended networkfunds that co-invest alongside them
Isomorphic Labs
London-based AI drug-design company spun out of Google DeepMind to reimagine the entire drug
Drug Discovery
Oura
The smart ring that turns sleep, stress, and heart data into AI health guidance
AI HealthcareAI Wearables
Aidoc
Clinical AI foundation model for medical imaging and triage
AI HealthcareAI Medical
Generate:Biomedicines
Generative AI for programmable protein therapeutics
AI HealthcareDrug Discovery
Proscia
AI-powered digital pathology for precision medicine
AI HealthcareDrug Discovery
Genesis Therapeutics
AI drug-discovery company building generative and predictive models to design small-molecule
Drug Discovery
- What is the 'anti-CRO' model?
- Lindus combines full-service trial operations with its own Citrus software instead of stitching together legacy vendors.
- What is Citrus?
- Lindus Health's AI-enabled eClinical platform for study design, monitoring, and biostatistics.
- How much did Lindus raise?
- A $55M Series B in January 2025 led by Balderton Capital.
Discussion
Sign in to join the discussion.
Sign inExplore more around Lindus Health
Contextual paths to related AI startups, deals and rankings.